2023-09-22
INBRAIN Neuroelectronics S.L., a health-tech company dedicated to developing the world’s first intelligent graphene-neural platform, announced that its Intelligent Network Modulation System has been granted Breakthrough Device Designation (BDD) from the U.S. Food & Drug Administration (FDA) as an adjunctive therapy for treating Parkinson’s disease.
